Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Re-epithelialization of 40 iatrogenic cornea ulcers produced in rabbits with iodine vapour burn were studied after topical administration of Betagan,
Betoptic
or Timoptic. At 24 hours there was no statistical difference in the wound healing rates among all the treated animal groups. At 48 hours, all the drug-treated groups were significantly different from the control group (p less than 0.05). There was no difference between the Betagan and
Betoptic
treated groups but the Timoptic-treated group was slower (p less than 0.05) than the
Betoptic
treated group, while the difference between the Timoptic and Betagan treated groups is not significant. At 72 hours the re-epithelialization rate of the Timoptic treated group was significantly slower than both the Betagan and
Betoptic
treated groups (p less than 0.05). By the 16th day following ulceration
SEM
examination revealed the Timoptic treated group had extensive epithelial cell desquamation, as well as hole formation and plasma membrane disruption. The Betagan treated corneas had mild superficial epithelial changes with loss of microvilli or slight desquamation. The
Betoptic
treated corneas were completely healed. In conclusion, Betagan is less toxic than Timoptic.
Betoptic
is the least toxic of the three drugs to regenerating rabbit corneal epithelium.
...
PMID:Toxic effects of topically administered Betagan, Betoptic, and Timoptic on regenerating corneal epithelium. 324 71